Archetype Therapeutics

Ownership

Private

Employees

Therapeutic Areas

OncologyPulmonology

Stage

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecules

Archetype Therapeutics General Information

Archetype Therapeutics uses AI and patient clinicogenomic data to virtually screen billions of drug-like molecules daily, predicting clinical outcomes for various diseases.

Contact Information

Website

https://www.archetypetx.com/

Primary Industry

Biotech

Corporate Office

Drug Pipeline

No pipeline data available

For full access to Archetype Therapeutics's pipeline data

Book a demo

Key Partnerships

Partnerships across the healthcare and life sciences ecosystem

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Archetype Therapeutics Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more

To view Archetype Therapeutics's complete valuation and funding history, request access »